Conclusions: Prevalence of obesity is increasing, and use of GLP-1 RAs as the preferred antiobesity medication has increased ...

Researchers are developing genomic screening tools to tailor radiation dose and hormone therapy for prostate cancer patients, ...

Confirmatory ZUMA-2 trial data led to full FDA approval of brexucabtagene autoleucel for patients with relapsed or refractory mantle cell lymphoma.

The FDA has granted traditional approval to brexucabtagene autoleucel (Tecartus; brexu-cel) for treatment of adult patients ...

Many terms have been invented to describe different types of hallucinogenic drugs, sometimes based on an analogy with the ...

Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in ...

The new Wegovy subscription program offers up to $1,200 in annual savings with predictable, tiered monthly pricing designed ...

Dr Memee Ahmad has issued a warning over the use of peptide injection after they become the latest ‘looksmaxxing’ trend ...

Poison control centers are seeing a sharp rise in kratom-related calls as doctors warn about the supplement’s risks. Dr. Ali ...

The death of 19-year-old Alex Duong from alveolar rhabdomyosarcoma has drawn public attention to a rare and aggressive cancer ...

The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.

Alternative cannabinoids walked through it. Over the past several years, hemp-derived compounds beyond CBD have built a hemp cannabinoid market worth an estimated $28 billion, driven by consumers ...